Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://esmeecvcs539672.verybigblog.com/37892589/retaglutide-a-promising-glp-1-receptor-agonist